IgAN Treatment Market Worth Over $6B By 2032: Analyst Bearish On Povetacicept's Promising Role

RBC Capital Markets initiated coverage on Alpine Immune Sciences Inc ALPN, noting that the autoimmune disease market (over $165 billion) is meaningful for the…

Related Keywords

Gregory Renza , Supawat Thongthip , Alpine Immune Sciences Inc , News , Ggregator , Reaking News , Uration , Media ,